Document Detail

Variations in adequate levothyroxine replacement therapy in patients with different causes of hypothyroidism.
MedLine Citation:
PMID:  15251659     Owner:  NLM     Status:  PubMed-not-MEDLINE    
OBJECTIVE: To compare the levothyroxine replacement dose in 181 patients with various causes of hypothyroidism. METHODS: We analyzed the dose of levothyroxine used in the following five patient groups: (1) 37 patients with hypothyroidism after radioiodine therapy for Graves' thyrotoxicosis who were receiving a stable (for at least 4 years) replacement dose (mean time after 131 I therapy, 11.3 years); (2) 36 patients with Hashimoto's hypothyroidism (chronic autoimmune thyroiditis with a goiter or positive test results for antithyroid antibodies); (3) 36 patients with central hypothyroidism; (4) 36 patients with hypothyroidism after near-total thyroidectomy and 131 I therapy for thyroid carcinoma with negative total-body 131 I scans who were euthyroid when receiving levothyroxine; and (5) 36 patients with atrophic thyroiditis (no goiter and negative test results for antithyroid antibodies). Adequacy of levothyroxine replacement dose was defined as a normal thyrotropin level and clinical euthyroidism in patients with primary hypothyroidism and a serum free thyroxine index in the upper half of the normal range in conjunction with clinical euthyroidism in patients with central hypothyroidism. RESULTS: The mean (+/- standard error of the mean) replacement dosage of levothyroxine (mg/kg per day) in patients with atrophic thyroiditis (1.26 +/- 0.07) was lower (P<0.05) than in patients with Hashimoto's hypothyroidism (1.59 +/- 0.07) and those with hypothyroidism after radioiodine therapy (1.56 +/- 0.05). These doses, in turn, were lower (P<0.01) than those in patients with central hypothyroidism (1.88 +/- 0.10) or euthyroid thyroid carcinoma (2.08 +/- 0.07). In a separate analysis, the levothyroxine dose in 43 patients with hypothyroidism after 131 I treatment was evaluated serially over time. The mean levothyroxine dosage increased from 0.87 +/- 0.12 at 6 months after 131 I therapy to 1.57 +/- 0.09 at 7 years (P<0.001). The serum thyrotropin concentration (in mU/mL) during levothyroxine therapy in patients with central hypothyroidism (0.31 +/- 0.08) was lower (P<0.01) than in patients with hypothyroidism after 131 I therapy (1.69 +/- 0.37), Hashimoto's hypothyroidism (1.39 +/- 0.20), atrophic thyroiditis (1.86 +/- 0.22), and euthyroid thyroid carcinoma (1.48 +/- 0.26). CONCLUSION: The levothyroxine replacement dose varies with the cause of the hypothyroidism.
M B Gordon; M S Gordon
Related Documents :
14512089 - Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid ...
20200629 - Hypothyroidism and renal function in patients with systolic heart failure.
17008939 - Surgery for hyperthyroidism in down syndrome: case report.
8548939 - A study of untreated graves' patients with undetectable tsh binding inhibitor immunoglo...
6603289 - Identification of subsets of patients with graves' disease by cluster analysis.
8082149 - A study of thyroid dysfunction in nigerian psychiatric outpatients.
12845979 - Hirschsprung's disease and its allied disorders in adults' histological and clinical st...
8705009 - Relationship between interferon-gamma, interleukin-4 and ige production of lymphocytes ...
23815959 - Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists     Volume:  5     ISSN:  1530-891X     ISO Abbreviation:  Endocr Pract     Publication Date:    1999 Sep-Oct
Date Detail:
Created Date:  2004-07-14     Completed Date:  2005-04-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9607439     Medline TA:  Endocr Pract     Country:  United States    
Other Details:
Languages:  eng     Pagination:  233-8     Citation Subset:  -    
Division of Endocrinology, Allegheny General Hospital, MCP/Hahnemann University Medical School, Pittsburgh, Pennsylvania, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Single-monthly-dose vitamin D supplementation in elderly patients.
Next Document:  Effects of carbamazepine on the hypothalamic-pituitary-thyroid axis.